Clostridium difficile infection: Difference between revisions
| Line 22: | Line 22: | ||
====Drug Side Effect==== | ====Drug Side Effect==== | ||
*[[Amoxicillin]] | * [[Amoxicillin]] | ||
*[[Meropenem]] | * [[Cefotaxime sodium]] | ||
* [[Meropenem]] | |||
* [[Mupirocin]] | * [[Mupirocin]] | ||
* [[Rifabutin]] | * [[Rifabutin]] | ||
Revision as of 14:38, 14 January 2015
|
Resident Survival Guide |
|
C. difficile Infection Microchapters |
|
Differentiating Clostridium difficile infectionfrom other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Clostridium difficile infection On the Web |
|
American Roentgen Ray Society Images of Clostridium difficile infection |
|
Risk calculators and risk factors for Clostridium difficile infection |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abhishek Deshpande, M.D., Ph.D.
Synonyms and keywords: CDI
Overview
Historical Perspective
Pathophysiology
Causes
Drug Side Effect
- Amoxicillin
- Cefotaxime sodium
- Meropenem
- Mupirocin
- Rifabutin
- Nitrofurantoin
- Pantoprazole
- Streptomycin
Differentiating Clostridium difficile from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Abdominal X Ray | CT | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies